STOCK TITAN

The Oncology Institute Warrant (TOIIW) Stock News, Jul 2023-Jan 2024

TOIIW NASDAQ

The Oncology Institute, Inc. provides value-based community oncology care through clinics and affiliate locations across multiple states. Company updates commonly cover quarterly results, payor and Medicare Advantage contract activity, capitated care models, specialty pharmacy performance, clinical trials, transfusions, and participation in CMS oncology care programs.

News also addresses clinical pathways, legal and compliance leadership, and healthcare investor conference participation. The issuer's public securities include common stock under TOI and redeemable warrants under TOIIW.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
52%
Tags
partnership
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
62%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
57.14%
Tags
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.97%
Tags
conferences earnings
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.97%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.98%
Tags
conferences
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.17%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10%
Tags
partnership AI
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10%
Tags
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-20.95%
Tags
partnership

FAQ

What is the current stock price of The Oncology Institute Warrant (TOIIW)?

The Oncology Institute Warrant (TOIIW) last closed at $0.049.